Purine derivatives for use as adenosin A-2A receptor agonists

Details for Australian Patent Application No. 2005298878 (hide)

Owner Novartis AG

Inventors Fairhurst, Robin Alec; Singh, Paul; Taylor, Roger John

Agent Davies Collison Cave

Pub. Number AU-B-2005298878

PCT Pub. Number WO2006/045552

Priority 0423551.1 22.10.04 GB; 0514619.6 15.07.05 GB

Filing date 21 October 2005

Wipo publication date 4 May 2006

Acceptance publication date 30 July 2009

International Classifications

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

A61K 31/52 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 473/32 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/40 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/045552 Priority application(s): WO2006/045552

30 July 2009 Application Accepted

  Published as AU-B-2005298878

26 November 2009 Standard Patent Sealed

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005298880-(Biphenyl) carboxylic acids and derivatives thereof

2005298863-Purification of glycopeptides